CAS 1374828-69-9
:GNE-0877
Description:
GNE-0877, identified by its CAS number 1374828-69-9, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of oncology. It is classified as a selective inhibitor of certain protein kinases, which play crucial roles in cell signaling pathways that regulate cell growth and division. The compound's mechanism of action typically involves the inhibition of specific kinases associated with cancer progression, making it a candidate for targeted cancer therapies. GNE-0877 is characterized by its ability to modulate biological pathways, potentially leading to reduced tumor growth and improved therapeutic outcomes. Its physicochemical properties, such as solubility, stability, and bioavailability, are essential for its efficacy and safety profile in clinical applications. Ongoing studies aim to elucidate its pharmacokinetics and pharmacodynamics, further establishing its role in cancer treatment regimens. As with many investigational compounds, comprehensive data on its long-term effects and interactions with other medications are still under evaluation.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
GNE0877
CAS:<p>GNE0877 (GNE 0877) is a highly effective and specific leucine-rich repeat kinase 2 (LRRK2) inhibitor (Ki: 0.7 nM).</p>Formula:C14H16F3N7Purity:98.01% - 99.97%Color and Shape:SolidMolecular weight:339.32GNE-0877
CAS:Controlled Product<p>Applications GNE-0877 is a highly potent and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor.<br>References Estrada, A., et al.: J. Med. Chem., 57, 921 (2014)<br></p>Formula:C14H16F3N7Color and Shape:NeatMolecular weight:339.32
